Predictive value of heparanase expression in the palliative therapy of pancreatic cancer.

Schoppmeyer, K; Kronberg, J; Tannapfel, A; Mossner, J; Wittekind, C; Caca, K

Schoppmeyer, K; Kronberg, J; Tannapfel, A; Mossner, J; Wittekind, C; Caca, K.

Affiliation

Schoppmeyer K; Department of Medicine II, Leipzig University, Germany.

Pancreatology ; 5(6): 570-5, 2005.

Article in En | MEDLINE | ID: mdl-16110255

Subject(s)

Adenocarcinoma/therapy; Biomarkers/analysis; Deoxycytidine/analogs & derivatives; Glucuronidase/biosynthesis; Palliative Care/methods; Pancreatic Neoplasms/therapy; Aged; Deoxycytidine/adverse effects; Deoxycytidine/therapeutic use; Female; Germany/epidemiology; Humans; Male; Middle Aged; Pancreatic Neoplasms/mortality; Predictive Value of Tests; Retrospective Studies; Survival Rate; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Pancreatic Neoplasms / Biomarkers / Adenocarcinoma / Deoxycytidine / Glucuronidase Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Pancreatology Journal subject: ENDOCRINOLOGIA / GASTROENTEROLOGIA Year: 2005 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links